Aktis Oncology (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- October 17, 2024
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $175,000,000
Company Info
- Organizations Involved
- Bristol Myers Squibb, Eli Lilly and Company, Merck & Co., Inc.
- Company Description
- Aktis Oncology is a clinical-stage biotechnology company pioneering the discovery and development of novel targeted alpha radiopharmaceuticals to treat a broad range of solid tumors.
- Market
- Clinical-stage oncology treatments
- Location
- Boston, MA, USA
- Coinvestors
- RA Capital Management, RTW Investments, Janus Henderson Investors, T. Rowe Price Associates, Avidity Partners, Bristol Myers Squibb, Eli Lilly and Company, MRL Ventures Fund